Fever with worsening belly pain
The reason is straightforward
However, controversial findings of nonspecific binding of [ 11 C]-dihydrotetrabenazine in human pancreas raised questions for its clinical application (Goland et al., 2009)
Some companies are beginning to cover for other conditions, including obesity, heart disease, obesity with sleep apnea or obesity with high blood pressure
The aim is to evaluate the utility of non-invasive biomarkersFIB-4, ELF, FAST, and VCTE (Fibroscan)in predicting liver fibrosis stages and their potential association with common comorbid conditions
The 2024 Lasker~DeBakey Clinical Medical Research Award honored three pioneering scientistsJoel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsenwhose research into GLP-1 (Glucagon-like peptide-1) has revolutionized weight management and offered new hope for millions of people struggling with obesity